Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer

Jun-Hui Sun; Tan-Yang Zhou; Yue-Lin Zhang; Guan-Hui Zhou; Chun-Hui Nie; Tong-Yin Zhu; Sheng-Qun Chen; Bao-Quan Wang; Song Ye; Yan Shen; Hua Guo; Wei-Lin Wang; Shu-Sen Zheng

doi:10.18632/oncotarget.24759

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer

PDF | How to cite

Oncotarget. 2018; 9:15435-15435. https://doi.org/10.18632/oncotarget.24759

Metrics: PDF 1713 views | ?

Jun-Hui Sun^1,2,3,4, Tan-Yang Zhou^1,2,3,4, Yue-Lin Zhang^1,2,3,4, Guan-Hui Zhou^1,2,3,4, Chun-Hui Nie^1,2,3,4, Tong-Yin Zhu^1,2,3,4, Sheng-Qun Chen^1,2,3,4, Bao-Quan Wang^1,2,3,4, Song Ye^1,2,3,4, Yan Shen^1,2,3,4, Hua Guo^1,2,3,4, Wei-Lin Wang^1,2,3,4 and Shu-Sen Zheng^1,2,3,4

¹ Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, First Af fliated Hospital, College of Medicine, Zhejiang University, China
² Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, China
³ Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang, Hangzhou, China
⁴ Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases, Zhejiang University, Hangzhou, Zhejiang, China

Published: March 16, 2018

This article has been corrected: The proper name of the institution is as follows:

¹ Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, College of Medicine, Zhejiang University, China

Original article: Oncotarget. 2017; 8:39746-39755. DOI: https://doi.org/10.18632/oncotarget.14642.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24759

Publication Alerts

Oncoscience

Post-Publication Promotion

Corrections:

Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer